skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis

Journal Article · · Journal of Nuclear Medicine
OSTI ID:458860
;  [1]
  1. Guy`s Hospital, London (United Kingdom)

Whole-body PET scanning was performed using {sup 18}F-fluorodeoxyglucose (FDG) in two patients with hilar lymphadenopathy in whom the clinical differential diagnosis was between sarcoidosis and lymphoma. Both patients were later proven to have sarcoidosis. Uptake of {sup 18}FDG was seen in both intra- and extrathoracic lesions as well as in associated erythema nodosum. One patient underwent a repeat scan after steroid therapy where a marked decrease in hilar uptake was seen. Fluorine-18-fluorodeoxyglucose uptake is observed in lymph nodes with sarcoid involvement. Further investigation is necessary to assess if quantitative differences exist between sarcoid and malignant lymphadenopathy. 30 refs., 3 figs.

OSTI ID:
458860
Journal Information:
Journal of Nuclear Medicine, Vol. 35, Issue 10; Other Information: PBD: Oct 1994
Country of Publication:
United States
Language:
English